Skip to main content

Table 3 Prevalence and intensity of Onchocerca volvulus microfilariae during ivermectin MDA (2001–2015), in sentinel and extra-sentinel communities of the Amazonian focus of southern Venezuela

From: Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus

Community

Positive/examined

Prevalence (%) of skin mf (95 % CI)

AM (mf/mg)

WM§ (mf/mg)

CMFL (mf/ss)

MFC (%)

MFAC¦ (%)

Sentinel communities

1 Hasupiwei

5/43b

11.6 (3.9, 25.1)

0.26

0.13

0.11

11.8

0

4/55c

7.3 (2.0, 17.6)

0.13

0.07

0.03

10.0

2.0

2 Awei

11/23a

47.8 (26.8, 69.4)

2.06

0.94

3.04

0/13b

0 (0, 24.7)

0

0

0

0

0

3 Pashopëka

20/28a

71.4 (51.3, 86.8)

1.74

0.88

1.04

10/32b

31.2 (16.1, 50.0)

2.51

0.17

1.60

11.1

7.4

1/49c

2.0 (0.10, 10.9)

0.03

0.02

0.03

4.5

0

4 Koyowë

60/77a

77.9 (67.0, 86.6)

16.4

4.7

20.2

36.0

13.0

24/58b

41.4 (28.6, 55.1)

3.4

1.1

1.9

20.4

6.1

7/98c

7.1 (2.9, 14.2)

0.18

0.09

0.17

11.9

0

5 Waharafitha

39/80b

48.8 (37.4, 60.2)

3.33

0.91

1.19

7.5

12.5

5/40c

12.5 (4.2, 26.8)

0.22

0.12

0.17

0

0

6 Matoa

14/35b

40.0 (23.9, 57.9)

3.66

0.91

1.03

8.3

0

7 Kanoshewë

1/11b

9.1 (0.2, 41.3)

0.06

0.05

0

0/25c

0 (0, 13.7)

0

0

0

8 Niayopë*

4/12b

33.3 (9.9, 65.1)

0.49

0.17

0

0/38c

0 (0, 9.3)

0

0

0

Extra-sentinel communities

9 Yaurawë

11/37b

29.7 (15.9, 47.0)

0.99

0.43

0.55

20.0

16.0

16/77c

20.8 (12.4, 31.5)

1.75

0.40

0.7

11.1

3.7

10 Masiriki

0/21c

0 (0, 16.1)

0

0

0c

11 Toumawei

2/25c

8.0 (1.0, 26.0)

0.10

0.05

0.10

12 Arokofita

0/21c

0 (0, 16.1)

0

0

0

13 Okiamo

0/38c

0 (0, 9.3)

0

0

0

14 Warapawë

3/30b

10.0 (2.1, 26.5)

0.04

0.04

0/31c

0 (0, 11.2)

0

0

0

15 Kakarama**

1/41c

2.4 (0.1, 12.9)

0.03

0.02

0.05

16 Pokoshiprare**

0/60c

0 (0, 6.0)

0

0

0

  1. AM arithmetic mean no. of mf/mg, § WM geometric mean (of Williams) no. of mf/mg; CMFL community microfilarial load, the geometric mean no. of mf per skin snip (ss) in those individuals aged ≥20 years; MFC prevalence of mf in cornea; ¦ MFAC prevalence of mf in the anterior chamber of the eye; a2001, b2008–2009, c2013– 2015; *formerly called Niyayowë; **Kakarama and Pokoshiprare originated from Yoreshiana A and B, studied by [26]